These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 30249694

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions.
    David A, Golparian D, Jacobsson S, Stratton C, Lan PT, Shimuta K, Sonnenberg P, Field N, Ohnishi M, Davies C, Unemo M.
    J Antimicrob Chemother; 2024 Sep 03; 79(9):2221-2226. PubMed ID: 39004438
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
    Hamasuna R, Ohnishi M, Matsumoto M, Okumura R, Unemo M, Matsumoto T.
    Microb Drug Resist; 2018 Sep 03; 24(1):30-34. PubMed ID: 28581359
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea.
    Scangarella-Oman NE, Hossain M, Perry CR, Tiffany C, Powell M, Swift B, Dumont EF.
    Sex Transm Infect; 2023 Feb 03; 99(1):64-69. PubMed ID: 36411033
    [Abstract] [Full Text] [Related]

  • 10. Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber In Vitro Infection Model.
    VanScoy BD, Scangarella-Oman NE, Fikes S, Min S, Huang J, Ingraham K, Bhavnani SM, Conde H, Ambrose PG.
    Antimicrob Agents Chemother; 2020 Sep 21; 64(10):. PubMed ID: 32661002
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
    Shigemura K, Shirakawa T, Okada H, Hinata N, Acharya B, Kinoshita S, Kofuku T, Kawabata M, Kamidono S, Arakawa S, Gotoh A.
    Sex Transm Dis; 2004 Mar 21; 31(3):180-4. PubMed ID: 15076932
    [Abstract] [Full Text] [Related]

  • 13. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
    Chaudhry U, Ray K, Bala M, Saluja D.
    Sex Transm Infect; 2002 Dec 21; 78(6):440-4. PubMed ID: 12473806
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of the microbiological characteristics of Neisseria gonorrhoeae isolated from male and female patients with gonorrhea.
    Saika T, Kobayashi I, Inoue M.
    Chemotherapy; 2004 Jun 21; 50(2):92-7. PubMed ID: 15211084
    [Abstract] [Full Text] [Related]

  • 16. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Fukuda H, Maeda S, Saito I, Kawada Y.
    Chemotherapy; 1997 Jun 21; 43(4):239-44. PubMed ID: 9209780
    [Abstract] [Full Text] [Related]

  • 17. Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002.
    Abe H, Nishimura T, Norose Y, Aoto T, Ohzuka H, Ohkuni H.
    J Infect Chemother; 2003 Dec 21; 9(4):310-3. PubMed ID: 14691651
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
    Hook EW, Golden MR, Taylor SN, Henry E, Tseng C, Workowski KA, Swerdlow J, Nenninger A, Cammarata S.
    Sex Transm Dis; 2019 May 21; 46(5):279-286. PubMed ID: 30985632
    [Abstract] [Full Text] [Related]

  • 20. High-frequency of quinolone-resistant Neisseria gonorrhoeae in Austria with a common pattern of triple mutations in GyrA and ParC genes.
    Uthman A, Heller-Vitouch C, Stary A, Bilina A, Kuchinka-Koch A, Söltz-Szöts J, Tschachler E.
    Sex Transm Dis; 2004 Oct 21; 31(10):616-8. PubMed ID: 15389000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.